Please use this identifier to cite or link to this item: https://hdl.handle.net/1959.11/60739
Full metadata record
DC FieldValueLanguage
dc.contributor.authorGravely, Shannonen
dc.contributor.authorGiovino, Gary Aen
dc.contributor.authorCraig, Lorraineen
dc.contributor.authorCommar, Alisonen
dc.contributor.authorTursan D'espaignet, Edouarden
dc.contributor.authorSchotte, Kerstinen
dc.contributor.authorFong, Geoffrey Ten
dc.date.accessioned2024-06-15T09:28:29Z-
dc.date.available2024-06-15T09:28:29Z-
dc.date.issued2017-04-
dc.identifier.citationThe Lancet Public Health, 2(4), p. e166-e174en
dc.identifier.issn2468-2667en
dc.identifier.urihttps://hdl.handle.net/1959.11/60739-
dc.description.abstract<p>Background The WHO Framework Convention on Tobacco Control (WHO FCTC) has mobilised efforts among 180 parties to combat the global tobacco epidemic. This study examined the association between highest-level implementation of key tobacco control demand-reduction measures of the WHO FCTC and smoking prevalence over the treaty’s first decade.</p> <p>Methods We used WHO data from 126 countries to examine the association between the number of highest-level implementations of key demand-reduction measures (WHO FCTC articles 6, 8, 11, 13, and 14) between 2007 and 2014 and smoking prevalence estimates between 2005 and 2015. McNemar tests were done to test differences in the proportion of countries that had implemented each of the measures at the highest level between 2007 and 2014. Four linear regression models were computed to examine the association between the predictor variable (the change between 2007 and 2014 in the number of key measures implemented at the highest level), and the outcome variable (the percentage point change in tobacco smoking prevalence between 2005 and 2015).</p> <p>Findings Between 2007 and 2014, there was a significant global increase in highest-level implementation of all key demand-reduction measures. The mean smoking prevalence for all 126 countries was 24·73% (SD 10·32) in 2005 and 22·18% (SD 8·87) in 2015, an average decrease in prevalence of 2·55 percentage points (SD 5·08; relative reduction 10·31%). Unadjusted linear regression showed that increases in highest-level implementations of key measures between 2007 and 2014 were significantly associated with a decrease in smoking prevalence between 2005 and 2015). Each additional measure implemented at the highest level was associated with an average decrease in smoking prevalence of 1·57 percentage points (95% CI –2·51 to –0·63, p=0·001) and an average relative decrease of 7·09% (–12·55 to –1·63, p=0·011). Controlling for geographical subregion, income level, and WHO FCTC party status, the per-measure decrease in prevalence was 0·94 percentage points (–1·76 to –0·13, p=0·023) and an average relative decrease of 3·18% (–6·75 to 0·38, p=0·079). This association was consistent across all three control variables.</p> <p>Interpretation Implementation of key WHO FCTC demand-reduction measures is significantly associated with lower smoking prevalence, with anticipated future reductions in tobacco-related morbidity and mortality. These findings validate the call for strong implementation of the WHO FCTC in the WHO’s Global Action Plan for the Prevention and Control of Non-communicable Diseases 2013–2020, and in advancing the UN’s Sustainable Development Goal 3, setting a global target of reducing tobacco use and premature mortality from non-communicable diseases by a third by 2030.</p>en
dc.languageenen
dc.publisherThe Lancet Publishing Groupen
dc.relation.ispartofThe Lancet Public Healthen
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 International*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.titleImplementation of key demand-reduction measures of the WHO Framework Convention on Tobacco Control and change in smoking prevalence in 126 countries: an association studyen
dc.typeJournal Articleen
dc.identifier.doi10.1016/s2468-2667(17)30045-2en
dcterms.accessRightsUNE Greenen
local.contributor.firstnameShannonen
local.contributor.firstnameGary Aen
local.contributor.firstnameLorraineen
local.contributor.firstnameAlisonen
local.contributor.firstnameEdouarden
local.contributor.firstnameKerstinen
local.contributor.firstnameGeoffrey Ten
local.profile.schoolSchool of Rural Medicineen
local.profile.emailetursan2@une.edu.auen
local.output.categoryC1en
local.record.placeauen
local.record.institutionUniversity of New Englanden
local.publisher.placeUnited Kingdomen
local.format.startpagee166en
local.format.endpagee174en
local.peerreviewedYesen
local.identifier.volume2en
local.identifier.issue4en
local.title.subtitlean association studyen
local.access.fulltextYesen
local.contributor.lastnameGravelyen
local.contributor.lastnameGiovinoen
local.contributor.lastnameCraigen
local.contributor.lastnameCommaren
local.contributor.lastnameTursan D'espaigneten
local.contributor.lastnameSchotteen
local.contributor.lastnameFongen
dc.identifier.staffune-id:etursan2en
local.profile.orcid0000-0002-5474-1803en
local.profile.roleauthoren
local.profile.roleauthoren
local.profile.roleauthoren
local.profile.roleauthoren
local.profile.roleauthoren
local.profile.roleauthoren
local.profile.roleauthoren
local.identifier.unepublicationidune:1959.11/60739en
dc.identifier.academiclevelAcademicen
dc.identifier.academiclevelAcademicen
dc.identifier.academiclevelAcademicen
dc.identifier.academiclevelAcademicen
dc.identifier.academiclevelAcademicen
dc.identifier.academiclevelAcademicen
dc.identifier.academiclevelAcademicen
local.title.maintitleImplementation of key demand-reduction measures of the WHO Framework Convention on Tobacco Control and change in smoking prevalence in 126 countriesen
local.relation.fundingsourcenoteHealth Canada, Canadian Institutes of Health Research, Ontario Institute for Cancer Research and Canadian Cancer Society Research Institute.en
local.output.categorydescriptionC1 Refereed Article in a Scholarly Journalen
local.search.authorGravely, Shannonen
local.search.authorGiovino, Gary Aen
local.search.authorCraig, Lorraineen
local.search.authorCommar, Alisonen
local.search.authorTursan D'espaignet, Edouarden
local.search.authorSchotte, Kerstinen
local.search.authorFong, Geoffrey Ten
local.open.fileurlhttps://rune.une.edu.au/web/retrieve/fc65f11b-83b5-4d11-b2f9-d0bec2bf846cen
local.uneassociationNoen
local.atsiresearchNoen
local.sensitive.culturalNoen
local.year.published2017en
local.fileurl.openhttps://rune.une.edu.au/web/retrieve/fc65f11b-83b5-4d11-b2f9-d0bec2bf846cen
local.fileurl.openpublishedhttps://rune.une.edu.au/web/retrieve/fc65f11b-83b5-4d11-b2f9-d0bec2bf846cen
local.subject.for20203214 Pharmacology and pharmaceutical sciencesen
local.profile.affiliationtypeExternal Affiliationen
local.profile.affiliationtypeExternal Affiliationen
local.profile.affiliationtypeExternal Affiliationen
local.profile.affiliationtypeExternal Affiliationen
local.profile.affiliationtypeExternal Affiliationen
local.profile.affiliationtypeExternal Affiliationen
local.profile.affiliationtypeExternal Affiliationen
local.date.moved2024-06-17en
Appears in Collections:Journal Article
School of Rural Medicine
Files in This Item:
2 files
File Description SizeFormat 
openpublished/ImplementationTursanD'espaignet2017JournalArticle.pdfPublished Version671.23 kBAdobe PDF
Download Adobe
View/Open
Show simple item record
Google Media

Google ScholarTM

Check

Altmetric


This item is licensed under a Creative Commons License Creative Commons